BlackRock, Inc.

Position in CRL — Charles River Laboratories International, Inc.

CIK 2012383 New York, NY

Position in CRL

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$665,694,745

-$83,223,780 QoQ

Shares Held

3,859,100

+2.8% QoQ

Ownership

8.01%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 94.65170635640435.ToString("F0")% Shared 0.ToString("F0")% None 5.348293643595657.ToString("F0")%

Healthcare · as of Mar 31, 2026

BlackRock, Inc. holds $54,004,955,805 across 42 Diagnostics & Research names. CRL ranks #14 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	30,427,192	$14,955,877,673
2	DHR	Danaher Corp /De/	51,640,619	$9,791,061,354
3	IDXX	Idexx Laboratories Inc /De	8,365,553	$4,700,520,563
4	A	Agilent Technologies, Inc.	25,902,662	$2,952,385,405
5	IQV	Iqvia Holdings Inc.	15,027,444	$2,562,780,290
6	WAT	Waters Corp /De/	8,543,014	$2,544,109,560
7	ILMN	Illumina, Inc.	19,023,590	$2,344,847,691
8	MTD	Mettler Toledo International Inc/	1,771,002	$2,233,587,712

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$665,694,745	3,859,100	+2.8%	Shares	Sole	2026-05-13
2025-12-31	$748,918,525	3,754,354	-2.6%	Shares	Sole	2026-02-12
2025-09-30	$603,320,079	3,856,066	+5.5%	Shares	Sole	2025-11-12
2025-06-30	$554,744,899	3,656,132	-0.4%	Shares	Sole	2025-08-12
2025-03-31	$552,532,571	3,670,825	-13.3%	Shares	Sole	2025-05-02
2024-12-31	$781,258,574	4,232,170	-0.1%	Shares	Sole	2025-02-07
2024-09-30	$834,825,034	4,238,336	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.